COVID

The study team included (front row, from left) Kelsey Voss, PhD, Rachel Bonami, PhD, Erin Wilfong, MD, PhD, (back row, from left) Jonathan Irish, PhD, Jeff Rathmell, PhD, and Ivelin Georgiev, PhD.

Vanderbilt team tracks cellular and antibody responses to COVID-19 vaccine

In a technical tour de force, a collaborative team of Vanderbilt researchers has characterized the antigen-specific immune response to the Pfizer SARS-CoV-2 RNA vaccine.

Convalescent plasma doesn’t help severely ill COVID patients: study

A Vanderbilt clinical trial shows that convalescent plasma, widely given to severely ill patients hospitalized with COVID-19 during the pandemic, does not improve their ability to survive or recover

Study shows two vaccine doses for mothers eases COVID complications for infants

Infants younger than 6 months were better protected from COVID-19 complications when mothers received two doses of the vaccine while pregnant, according to Vanderbilt researchers.

Occupational Health offers tips to kick off summer on a healthy note

We are officially into summer, which means vacations are ramping up. As you write your checklist, pack your suitcase, and book your trip, here are few important reminders.

COVID-19 vaccines for children 6 months through 4 years available

Children ages 6 months through age 4 years are now eligible to get the COVID-19 vaccine. Monroe Carell Jr. Children’s Hospital at Vanderbilt will offer vaccines for this age group on Wednesday, Thursday, and Friday, June 22, 23 and 24. Appointments are required and available between 2 p.m. and 5:30 p.m.
 
Saturday, June 25. Appointments are required and available between 8 a.m. and 11:30 a.m.

VUMC research aids approval of COVID-19 vaccine for young children

The U.S. Food and Drug Administration is expected to authorize Pfizer and Moderna’s COVID-19 vaccines for children as young as 6 months old as early as tomorrow, following the unanimous recommendation by an FDA advisory panel on Wednesday.

1 3 4 5 6 7 40